NASDAQ:OMPI - Obagi Medical Products Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Obagi Medical Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Obagi Medical Products, Inc (Obagi) is a specialty pharmaceutical company that develops, markets and sells, and is a provider of, topical aesthetic and therapeutic prescription-strength skin care systems and related products in the physician-dispensed market. Obagi systems and products are designed to prevent and improve the common and visible skin disorders in adult skin, including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, facial redness, and soft tissue deficits, such as fine lines and wrinkles. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:OMPI Previous Symbol CUSIPN/A CIK1375247 Webhttp://www.obagi.com/ Phone+1-562-6281007Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive OMPI News and Ratings via Email Sign-up to receive the latest news and ratings for OMPI and its competitors with MarketBeat's FREE daily newsletter. Obagi Medical Products (NASDAQ:OMPI) Frequently Asked Questions What is Obagi Medical Products' stock symbol? Obagi Medical Products trades on the NASDAQ under the ticker symbol "OMPI." Has Obagi Medical Products been receiving favorable news coverage? Media headlines about OMPI stock have been trending very negative recently, InfoTrie reports. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Obagi Medical Products earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned news coverage about the specialty pharmaceutical company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Obagi Medical Products. What is Obagi Medical Products' official website? The official website for Obagi Medical Products is http://www.obagi.com/. How can I contact Obagi Medical Products? Obagi Medical Products' mailing address is 50 Technology Drive, IRVINE, CA 92618, United States. The specialty pharmaceutical company can be reached via phone at +1-562-6281007. MarketBeat Community Rating for Obagi Medical Products (NASDAQ OMPI)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 96 (Vote Outperform)Underperform Votes: 90 (Vote Underperform)Total Votes: 186MarketBeat's community ratings are surveys of what our community members think about Obagi Medical Products and other stocks. Vote "Outperform" if you believe OMPI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OMPI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/8/2019 by MarketBeat.com StaffFeatured Article: Why do corrections happen?